ERIM
MACK

Eagle Ridge Investment Management’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History

Eagle Ridge Investment Management’s Portfolio MACK Stock Details MACK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-12,059
Closed -$807K – 123
2015
Q3 		$807K Sell
12,059
-3,511
-23% -$287K 0.21% 80
2015
Q2 		$1.51M Buy
15,570
+636
+4% +$60.5K 0.68% 34
2015
Q1 		$1.4M Buy
14,934
+3,177
+27% +$270K 0.63% 35
2014
Q4 		$1.04M Buy
11,757
+1,271
+12% +$92.6K 0.48% 36
2014
Q3 		$724K Hold
10,486
– – 0.35% 39
2014
Q2 		$601K Buy
10,486
+7,944
+313% +$403K 0.28% 43
2014
Q1 		$101K Buy
+2,542
New +$109K 0.05% 57

Other funds holding MACK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
TCIM
TIAA CREF Investment Management New York $141B AUM 14.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return

Eagle Ridge Investment Management's MACK Position: Q4 2015 in Review

Eagle Ridge Investment Management sold out of Merrimack Pharmaceuticals, Inc. (MACK) in Q4 2015, closing a stake of 12,059 shares — an estimated $807K sold.

Eagle Ridge Investment Management first reported a position in MACK in Q1 2014 and held it in 7 quarters. The position peaked at $1.51M in Q2 2015. 139 funds tracked by Wall St. Rank hold MACK as of Q4 2015.

  • Eagle Ridge Investment Management reported no remaining Merrimack Pharmaceuticals, Inc. position as of Q4 2015 after selling out during the quarter.
  • Eagle Ridge Investment Management sold 12,059 Merrimack Pharmaceuticals, Inc. shares in Q4 2015, an estimated $807K.
  • Eagle Ridge Investment Management first reported a position in Merrimack Pharmaceuticals, Inc. in Q1 2014 and held it in 7 quarters.
  • Eagle Ridge Investment Management's Merrimack Pharmaceuticals, Inc. position peaked at $1.51M in Q2 2015.
  • 139 funds tracked by Wall St. Rank held Merrimack Pharmaceuticals, Inc. as of Q4 2015.

Based on Eagle Ridge Investment Management's 13F filing for Q4 2015, filed 29 Jan 2016.